Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Diabetes Care Devices | Medical Devices | $42.6 Bn | 5.9% |
| Insulin Delivery Devices | Medical Devices | $15.9 Bn | 6.5% |
Named as key players in the same markets as Novo Nordisk A/S (number of shared markets).
Medtronic2 shared markets
AgaMatrix Holdings LLC1 shared market
Ascensia Diabetes Care Holdings AS1 shared market
Bionime Corporation1 shared market
Dexcom, Inc.1 shared market
Eli Lilly and Company1 shared market
Insulet Corporation1 shared market